Minerva director granted options on 50,000 shares
Minerva Neurosciences director David Kupfer received a grant of stock options covering 50,000 shares of common stock.
Rhea-AI Filing Summary
Minerva Neurosciences director David Kupfer received a grant of stock options covering 50,000 shares of common stock. The options have an exercise price of $4.68 per share and expire on June 2, 2036. Following this award, he holds options for 50,000 shares directly.
The grant vests in four equal quarterly installments, with one-quarter vesting three months after June 3, 2026 and an additional quarter vesting every three months thereafter, subject to his continued service as a non-employee director on each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
Kupfer David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 50,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.
Key Figures
Options granted: 50,000 options
Exercise price: $4.68 per share
Post-grant option holdings: 50,000 options
+2 more
5 metrics
Options granted
50,000 options
Stock Option (right to buy) covering common stock
Exercise price
$4.68 per share
Conversion/exercise price for granted options
Post-grant option holdings
50,000 options
Total derivative shares following transaction
Option expiration
June 2, 2036
Expiration date of granted stock options
Vesting structure
4 equal quarterly installments
First quarter vests three months after June 3, 2026
Key Terms
Stock Option (right to buy), exercise price, vesting, non-employee director, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 4.6800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to this option vest in four equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
non-employee director financial
"subject in each case to the continued service of the Reporting Person as a non-employee director"
expiration date financial
"expiration_date: 2036-06-02T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Minerva Neurosciences (NERV) director David Kupfer report in this Form 4?
David Kupfer reported receiving a grant of stock options for 50,000 Minerva Neurosciences shares. The options are a compensation award, giving him the right to buy common stock at a fixed exercise price if vesting and other conditions are met.
What is the exercise price of David Kupfer’s Minerva Neurosciences (NERV) stock options?
The options have an exercise price of $4.68 per share. This means Kupfer can purchase Minerva Neurosciences common stock at $4.68 for each option that vests and is exercised, if he chooses to do so before expiration.
When do David Kupfer’s Minerva Neurosciences (NERV) stock options expire?
The stock options expire on June 2, 2036. Kupfer must exercise any vested options before that expiration date; otherwise, the right to purchase those Minerva Neurosciences shares at the set exercise price will lapse.
How do the Minerva Neurosciences (NERV) stock options granted to Kupfer vest over time?
The 50,000 options vest in four equal quarterly installments. One-quarter vests three months after June 3, 2026, with an additional quarter vesting every three months thereafter, contingent on his continued service as a non-employee director.
AI-generated analysis. How Rhea-AI works. Not financial advice.
